Initiation Archives - Page 121 of 272

1 minute read

Cowen & Co. Initiates Coverage On OneSpaWorld Holdings with Outperform Rating, Announces Price Target of $13

December 14, 8:49 AM

Cowen & Co. analyst Max Rakhlenko initiates coverage on OneSpaWorld Holdings (NASDAQ:OSW) with a Outperform rating and announces Price Target of $13.

OSW

1 minute read

Morgan Stanley Initiates Coverage On Broadridge Financial Soln with Equal-Weight Rating, Announces Price Target of $160

By Benzinga Newsdesk

December 14, 8:40 AM

Morgan Stanley analyst James Faucette initiates coverage on Broadridge Financial Soln (NYSE:BR) with a Equal-Weight rating and announces Price Target of $160.

1 minute read

Needham Initiates Coverage On Day One Biopharmaceutical with Buy Rating, Announces Price Target of $40

By Benzinga Newsdesk

December 14, 8:39 AM

Needham analyst Ami Fadia initiates coverage on Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy rating and announces Price Target of $40.

DAWN

1 minute read

Goldman Sachs Initiates Coverage On PTC Therapeutics with Sell Rating, Announces Price Target of $35

By Benzinga Newsdesk

December 14, 8:28 AM

Goldman Sachs analyst Paul Choi initiates coverage on PTC Therapeutics (NASDAQ:PTCT) with a Sell rating and announces Price Target of $35.

PTCT

1 minute read

Goldman Sachs Initiates Coverage On Xenon Pharmaceuticals with Buy Rating, Announces Price Target of $60

By Benzinga Newsdesk

December 14, 8:27 AM

Goldman Sachs analyst Paul Choi initiates coverage on Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy rating and announces Price Target of $60.

XENE

1 minute read

Keybanc Initiates Coverage On RPM International with Sector Weight Rating

By Benzinga Newsdesk

December 14, 7:50 AM

Keybanc analyst Aleksey Yefremov initiates coverage on RPM International (NYSE:RPM) with a Sector Weight rating.

RPM

1 minute read

Needham Initiates Coverage On Blueprint Medicines with Buy Rating, Announces Price Target of $60

By Benzinga Newsdesk

December 14, 7:33 AM

Needham analyst Ami Fadia initiates coverage on Blueprint Medicines (NASDAQ:BPMC) with a Buy rating and announces Price Target of $60.

BPMC

1 minute read

Canaccord Genuity Initiates Coverage On Pagaya Technologies with Hold Rating, Announces Price Target of $1.5

By Benzinga Newsdesk

December 14, 6:30 AM

Canaccord Genuity analyst Joseph Vafi initiates coverage on Pagaya Technologies (NASDAQ:PGY) with a Hold rating and announces Price Target of $1.5.

PGY

1 minute read

Deutsche Bank Initiates Coverage On Avantor with Hold Rating, Announces Price Target of $24

By Benzinga Newsdesk

December 14, 6:05 AM

Deutsche Bank analyst Justin Bowers initiates coverage on Avantor (NYSE:AVTR) with a Hold rating and announces Price Target of $24.

AVTR

1 minute read

Deutsche Bank Initiates Coverage On Bio-Techne with Buy Rating, Announces Price Target of $100

By Benzinga Newsdesk

December 14, 6:03 AM

Deutsche Bank analyst Justin Bowers initiates coverage on Bio-Techne (NASDAQ:TECH) with a Buy rating and announces Price Target of $100.

TECH